Now that former shareholders of Sprout Pharmaceuticals, maker of controversial female libido pill Addyi, have the company back in their hands, they’ve reinstalled a familiar face at the helm. Cindy Eckert, who went by Cindy Whitehead during her last stint as CEO, is once again in the company’s top spot, Fortune reported. She vacated that position after Valeant bought Sprout back in 2015, a deal the serial buyer announced just one day after Eckert and co. snagged a third-try FDA appro...
FIERCEPHARMA
READ MORE
|
Research and Markets has announced the addition of the "Pharmaceutical Analytical Testing Outsourcing Market Analysis By Services (Bioanalytical Testing, Method Development and Validation, Stability Testing), By Region And Segment Forecasts, 2014 - 2025" report to their offering....
READ MORE
|
Pharma has suffered another defeat in the state-by-state war over drug prices. On Tuesday, Oregon Gov. Kate Brown signed a bill that seeks to fight high costs and bring transparency to pharmaceutical pricing. Oregon's HB 4005 requires drugmakers to report R&D and marketing costs, profits and more for drugs that get price hikes of more than 10%, according to a release from the group behind the bill, Oregonians for Affordable Drug Prices Now. Companies must also report whether generics are...
FIERCEPHARMA
READ MORE
|
Supercomputer simulations show that at the atomic level, material stress doesn't behave symmetrically. Molecular model of a crystal containing a dissociated dislocation, atoms are encoded with the atomic shear strain. Below, snapshots of simulation results showing the relative positions of atoms in the rectangular prism elements; each element has dimensions 2.556 Å by 2.087 Å by 2.213 Å and has one atom at the center. Credit: Liming Xiong.
It's easy to take a lot...
READ MORE
|
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious Diseases. The results are significant as public health experts have long warned that the parasite responsible for most malaria cases, Plasmodium falciparum, is developing resistance to widely used treatments....
READ MORE
|
Drug firm Lupin Friday said it has launched generic Levothyroxine Sodium tablets in the US market. The company has launched Levothyroxine Sodium tablets USP after receiving approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a BSE filing. The company's product is the generic version of AbbVie Inc's Synthroid tablets, it added. The tablets are indicated as the replacement or supplemental therapy for hypothyroidism and as an adjunct to surgery and ra...
READ MORE
|